0001334549-24-000002.txt : 20240111
0001334549-24-000002.hdr.sgml : 20240111
20240111161038
ACCESSION NUMBER: 0001334549-24-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240109
FILED AS OF DATE: 20240111
DATE AS OF CHANGE: 20240111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mazzo David J
CENTRAL INDEX KEY: 0001334549
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33650
FILM NUMBER: 24529364
MAIL ADDRESS:
STREET 1: 110 ALLEN ROAD
STREET 2: 2ND FLOOR
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LISATA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0000320017
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 222343568
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 ALLEN ROAD
STREET 2: SECOND FLOOR
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
BUSINESS PHONE: 908-229-2590
MAIL ADDRESS:
STREET 1: 110 ALLEN ROAD
STREET 2: SECOND FLOOR
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
FORMER COMPANY:
FORMER CONFORMED NAME: CALADRIUS BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20170808
FORMER COMPANY:
FORMER CONFORMED NAME: Caladrius Biosciences, Inc.
DATE OF NAME CHANGE: 20150608
FORMER COMPANY:
FORMER CONFORMED NAME: NeoStem, Inc.
DATE OF NAME CHANGE: 20060906
4
1
wk-form4_1705007427.xml
FORM 4
X0508
4
2024-01-09
0
0000320017
LISATA THERAPEUTICS, INC.
LSTA
0001334549
Mazzo David J
C/O LISATA THERAPEUTICS, INC.
110 ALLEN ROAD, 2ND FLOOR
BASKING RIDGE
NJ
07920
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-01-09
4
A
0
94000
0
A
199308
D
Common Stock
2024-01-09
4
F
0
12203
3.08
D
187105
D
Common Stock
2024-01-09
4
F
0
7843
3.08
D
179262
D
Common Stock
2024-01-10
4
F
0
3470
3
D
175792
D
Stock Option (Right to Buy)
3.08
2024-01-09
4
A
0
47000
0
A
2024-01-09
2034-01-09
Common Stock
47000
47000
D
Represents 94,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
Includes 115,850 unvested restricted stock.
Shares withheld as payment of a tax liability on vesting of restricted stock.
Includes 109,166 unvested restricted stock.
One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.
James Nisco, Attorney-in-Fact for David J. Mazzo
2024-01-11